A Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics Study
Conditions: Solid Neoplasms; Carcinoma, Non-Small-Cell Lung; Prostatic Neoplasms Intervention: Drug: TAK-573 Sponsor: Millennium Pharmaceuticals, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials